Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies. - Wikidata - wikimedia - TriplyDB

Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies.

Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies.

http://www.wikidata.org/entity/Q44560037

about

Statin use and risk of prostate cancer: a meta-analysis of observational studies Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses Chemoprevention agents for prostate cancer Statin Use in Prostate Cancer: An Update Obesity and cancer: mechanistic insights from transdisciplinary studies Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis Targeting intratumoral androgens: statins and beyond Cholesterol and benign prostate disease.Statin drug use is not associated with prostate cancer risk in men who are regularly screened.Statin and NSAID use and prostate cancer risk 5-α reductase inhibitors and prostate cancer prevention: where do we turn now?Statin use and cancer risk: a comprehensive review Exposure to statins and risk of common cancers: a series of nested case-control studies.A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review).Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness.Prevention and early detection of prostate cancer.Use of fibrates and cancer risk: a systematic review and meta-analysis of 17 long-term randomized placebo-controlled trials The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted County study.Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer.Is statin use associated with prostate cancer aggressiveness?The association between statin use and the diagnosis of prostate cancer in a population based cohort Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins New analysis reexamines the value of cancer care in the United States compared to Western Europe Genome-wide integrative analysis revealed a correlation between lengths of copy number segments and corresponding gene expression profile.Anti-inflammatory drugs, antioxidants, and prostate cancer prevention.Prognostic impact of preoperative statin use after radical nephroureterectomy for upper urinary tract urothelial carcinoma.LDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies.Statin Use Reduces Prostate Cancer All-Cause Mortality: A Nationwide Population-Based Cohort Study Statin use and risk of prostate cancer in the prospective Osteoporotic Fractures in Men (MrOS) Study.Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate.Statin use in relation to prostate cancer outcomes in a population-based patient cohort study.Dyslipidemia, statins and prostate cancer.Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies.Statins: do they have a potential role in cancer prevention and modifying cancer-related outcomes?A review of statin use and prostate cancer.The current evidence on statin use and prostate cancer prevention: are we there yet?

P2860

Q21133952-A6309A99-35FA-40CD-B162-713C58DA615B Q24289205-D00A2419-6C7F-482F-8EB4-323DE304852E Q26471702-96B2FDB4-C23D-462F-9DD3-B0BE008291E7 Q26738631-75876C7F-5E13-4057-B5DA-F42368227E85 Q26786829-CCEFA103-B1AE-47BF-BF30-8ACE644D129A Q26864624-7D3E7EBF-2E67-454E-BED7-0DAD05750631 Q27000727-E6F373A3-6510-4A97-A631-45BF382F3801 Q28073619-17585069-1616-4E26-8C00-3BBC3C72CA8B Q33732687-3DC7619B-B055-422C-8CB2-D431BBCD3023 Q33922625-675593FD-1A37-4954-B0E8-C2F4C2B203A0 Q34003588-8CAD00E9-E093-4E49-AF2A-2D4574952CC1 Q34020127-44E6CD9C-9B5D-4B62-A2EA-35D4177ECE13 Q34021312-88854132-C95D-4FD5-B543-0E7D403E3AC2 Q34028899-A2F98290-5B63-4E45-A50A-D6F226C9BB84 Q34141355-BF3D0D55-E3CC-40E9-9C07-068024402CCA Q34158413-16492237-3E75-435F-8D20-96F945C805E5 Q34371057-574B6A8F-AEE4-4109-9717-606977173878 Q34428524-AA3F43FE-AA72-491E-8AF2-010527895D7F Q34458958-B540A5E4-3DBD-4531-9603-F6D541F423E1 Q34502662-82286CF9-FBF4-4836-8BF7-61A25FF816A5 Q34846143-74A373FE-5118-43BE-81B9-9233D6575429 Q34976557-BA56259A-F05B-4017-BAF2-C67DBAF243B5 Q35114991-06931067-81A2-4ECD-A775-BED1A894E906 Q35264079-80B6EC25-0CBD-47C8-BA58-4C7630A17780 Q35621404-A6DBC3F7-DA9F-4F32-AB0B-18092ED0FC94 Q35759844-9861ED2B-42AE-4095-B849-4D699755CFA4 Q35775751-B565ED10-2EFF-4F69-BA81-8B079E606ED3 Q35847370-DC685EEC-EC62-4755-B3F9-297B7457848C Q35988999-1DB16370-03EE-4952-8122-DE74765E95E1 Q36195699-85D366FF-77F5-4FE8-B291-DEC69D872062 Q36372128-D9D04111-7F54-4008-A950-1D41904E026C Q37071328-C0E39F68-7D0E-4AAA-BEA9-699B00BF2118 Q37072692-7F3641E2-1C71-4C69-A4CF-1084AE8C7C76 Q37226646-AA37A6CB-369A-4BBC-8E98-74EE0C9C2A9C Q37667939-45F1CC2D-D59A-4611-B08B-7D9D6CA431F3 Q38030598-76F94C62-920D-4F35-9711-CE71EC9220A6 Q38047044-70966546-B3DF-4EB0-B55F-ADEF9C97FDBC Q38257464-2068843F-33FE-48F1-96B9-F40A3D05D37E Q38272644-D93BF63A-83B0-48B8-91AA-BAF4AD7E9802 Q38800777-B4B99EEF-22F7-459F-BBF4-2FA0372716DC

P2860

Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies.

http://www.wikidata.org/entity/Q44560037

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Statin use and the risk of pro ...... and 13 observational studies.

@en

Statin use and the risk of pro ...... and 13 observational studies.

@nl

type

label

Statin use and the risk of pro ...... and 13 observational studies.

@en

Statin use and the risk of pro ...... and 13 observational studies.

@nl

prefLabel

Statin use and the risk of pro ...... and 13 observational studies.

@en

Statin use and the risk of pro ...... and 13 observational studies.

@nl

P1433

Q44560037-058380B6-2396-45AB-AF82-443EB1DB446F

P1476

Q44560037-E5B03E5C-C018-4F9A-A678-52755D0D0920

P2093

Q44560037-12B6CCB5-54A6-4454-B76F-40B986CCE0E5

Q44560037-3B3D9F2A-6279-49DB-8161-CFF06217EEB1

Q44560037-C5A98421-D65E-475E-9291-09DDE9202E73

P2860

Q44560037-07F14341-C804-439E-A61C-C3381C1EAB26

Q44560037-18DF71BC-FE86-4AB6-9D3A-5C270332AE04

Q44560037-1FE8B687-170C-4F5E-8978-564BCA10D649

Q44560037-229F51E3-7DE7-443F-8919-6F23C422EEE3

Q44560037-2300FB67-D083-402B-8BF6-9CCBFB8293B2

Q44560037-2969334E-5543-49D1-B0CF-6BE6E7188FBE

Q44560037-2CAFA7B5-2896-4D2C-8EED-796FA7E8E058

Q44560037-2E783D13-037C-4B2B-97C6-6F6A63E96D0C

Q44560037-31122F7B-7D0E-4E17-90F8-27AD6DACBDA4

Q44560037-32E73359-6035-4984-B802-9F3F25A3A08D

P304

Q44560037-F05D6A64-4FAE-48BF-B492-959F50E56BC6

P31

Q44560037-9B455AA4-957C-4068-968E-CBFE0742EF79

Q44560037-fa508049-9bf9-4d0d-92df-407de2824462

P356

Q44560037-00B505A7-EE20-44F1-AF0E-418A09E880A3

P433

Q44560037-B775F521-F791-48E6-89F4-D574FA2CF275

P478

Q44560037-ED48E505-A7CC-485A-B2D6-146885EF4F5E

P577

Q44560037-6F34F47B-BF19-4481-ABAE-88D204DD89DB

P5875

Q44560037-1FD3128F-BB08-4C73-8533-D3184628C8C6

P698

Q44560037-11B80D55-0DB2-455E-94D3-4746ABF6607F

P356

P1433

International Journal of Cancer

P1476

Statin use and the risk of pro ...... and 13 observational studies.

@en

P2093

Kalitsa Filioussi

http://www.w3.org/2001/XMLSchema#string

Nikolaos M Sitaras

http://www.w3.org/2001/XMLSchema#string

Stefanos Bonovas

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized, controlled trials, observational studies, and the hierarchy of research designs

Bias in meta-analysis detected by a simple, graphical test

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]

Global cancer statistics, 2002

Operating characteristics of a rank correlation test for publication bias

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a meta-analysis

Meta-analysis in clinical trials

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

P304

899-904

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.23550

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5359846

http://www.w3.org/2001/XMLSchema#string

P698

18491405

http://www.w3.org/2001/XMLSchema#string